Q3 2024: Group accelerates growth, driven by all business sectors

The company accelerated its growth in the third quarter of 2024. All three business sectors achieved organic increases in sales and earnings.

Key facts and Forecast

Financial results of Q3 2024

  • Net sales up organically by 3.8% to €5.3 billion
  • EBITDA pre up organically by 16.9% to €1.6 billion
  • EBITDA pre margin increases to 30.7%
  • Life Science returns to organic sales growth
  • Healthcare delivers solid sales growth and outstanding profitability
  • Electronics achieves another quarter of profitable growth

Forecast for fiscal 2024

  • Company confirms and specifies guidance for fiscal 2024

Overview: business performance in Q3 2024

 

 

Q3 2024 (in € billion)

Change (in %, compared to Q3 2023)

Organic change  (in %, compared to Q3 2023)

Group net sales

5.3        

1.8

3.8

EBITDA pre

1.6        

11.9

16.9

Life Science sales

2.2

0.9

2.1

Healthcare sales

2.1

3.2

6.2

Electronics sales

0.9

0.8

2.4

Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

“As expected, we continued our growth course in the third quarter. We confirm our guidance of profitable growth in fiscal 2024."

Belén Garijo

Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

Conference calls for the media and analysts

Related News

View All News
  1. Press Releases

    Q3 2024: Group accelerates growth, driven by all business sectors

    The company accelerated its growth in the third quarter of 2024. All three business sectors achieved organic increases in sales and earnings.

    2024/11/14

Upcoming Events

View All Events

Esther Döringer

Media Relations

Constantin Fest

Head of Investor Relations

+49 6151 72-5271

+49 6151 72 91-5271

Annual Reports Archive

Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more

Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.

Check Share Price